SEC Form 4 research
| Issuer | BridgeBio Pharma, Inc. |
|---|---|
| Tickers | BBIO |
| Reporting owners | 47 |
| Officers and directors | 18 |
| Last public filing | 2026-09-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-21 | 2026-09-17 | Kumar Neil | S | 1,279 | $69.57 | Not reported |
| 2026-09-21 | 2026-09-17 | Kumar Neil | S | 8,721 | $69.01 | Not reported |
| 2026-08-20 | 2026-08-19 | Kumar Neil | S | 100 | $85.65 | Not reported |
| 2026-08-20 | 2026-08-19 | Kumar Neil | S | 1,800 | $84.69 | Not reported |
| 2026-08-20 | 2026-08-19 | Kumar Neil | S | 8,100 | $83.86 | Not reported |
| 2026-08-20 | 2026-08-18 | Kumar Neil | S | 1,199 | $83.77 | Not reported |
| 2026-08-20 | 2026-08-18 | Kumar Neil | S | 14,602 | $82.99 | Not reported |
| 2026-08-20 | 2026-08-18 | Kumar Neil | S | 17,279 | $82.21 | Not reported |
| 2026-08-20 | 2026-08-18 | Kumar Neil | S | 1,900 | $81.15 | Not reported |
| 2026-08-03 | 2026-07-30 | Apuli Maricel | S | 2,000 | $80.06 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.